444
Views
19
CrossRef citations to date
0
Altmetric
Review

IL-1β: a key modulator in asthmatic airway smooth muscle hyper-reactivity

References

  • Sandberg S, et al. The role of acute and chronic stress in asthma attacks in children. Lancet 2000;356(9234):982-7
  • Panettieri RAJr. Asthma persistence versus progression: does airway smooth muscle function predict irreversible airflow obstruction? Allergy Asthma Proc 2009;30(2):103-8
  • Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70(3):171-9
  • Hirst SJ. Airway smooth muscle as a target in asthma. Clin Exp Allergy 2000;30(Suppl 1):54-9
  • Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006;7(2):95-100
  • Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 2007;29(2):379-89
  • Gohlke H, Illig T, Bahnweg M, et al. Association of the interleukin-1 receptor antagonist gene with asthma. Am J Respir Crit Care Med 2004;169(11):1217-23
  • Konno S, Gonokami Y, Kurokawa M, et al. Cytokine concentrations in sputum of asthmatic patients. Int Arch Allergy Immunol 1996;109:73-8
  • Pujol JL, Cosso B, Daures JP, et al. Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int Arch Allergy Appl Immunol 1990;91:207-10
  • Janssen LJ, Killian K. Airway smooth muscle as a target of asthma therapy: history and new directions. Respir Res 2006;7:123
  • Morishima H, Kajiwara K, Akiyama K, Yanagihara Y. Ligation of Toll-like receptor 3 differentially regulates M2 and M3 muscarinic receptor expression and function in human airway smooth muscle cells. Int Arch Allergy Immunol 2008;145(2):163-74
  • Broide DH, Lotz M, Cuomo AJ, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67
  • Rynko AE, Fryer AD, Jacoby DB. Interleukin-1β mediates virus-induced m2 muscarinic receptor dysfunction and airway hyperreactivity. Am J Respir Cell Mol Biol 2014;51(4):494-501
  • Wei-xu H, Qin X, Zhu W, et al. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin. Mol Immunol 2014;58(1):139-49
  • Horiba M, Qutna N, Gendapodi P, et al. Effect of IL-1β and TNF-α vs IL-13 on bronchial hyperresponsiveness, β2-adrenergic responses and cellularity of bronchial alveolar lavage fluid. Auton Autacoid Pharmacol 2011;31(3-4):37-49
  • Esnault S, Kelly EA, Nettenstrom LM, et al. Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes. Clin Exp Allergy 2012;42(12):1756-64
  • Knox AJ, Pang L, Johnson S, Hamad A. Airway smooth muscle function in asthma. Clin Exp Allergy 2000;30(5):606-14
  • Janssen LJ, Tazzeo T, Zuo J. Enhanced myosin phosphatase and Ca(2+)-uptake mediate adrenergic relaxation of airway smooth muscle. Am J Respir Cell Mol Biol 2004;30(4):548-54
  • Liu C, Zuo J, Janssen LJ. Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli. Eur Respir J 2006;28(4):703-11
  • Broide DH, Lawrence T, Doherty T, et al. Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium. Proc Natl Acad Sci USA 2005;102(49):17723-8
  • Rydell-Tormanen K, Risse PA, Kanabar V, et al. Smooth muscle in tissue remodeling and hyper-reactivity: Airways and arteries. Pulm Pharmacol Ther 2012;26(1):13-23
  • Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68(11):6398-401
  • Niimi K, Asano K, Shiraishi Y, et al. TLR3-mediated synthesis and release of eotaxin-1/CCL11 from human bronchial smooth muscle cells stimulated with double-stranded RNA. J Immunol 2007;178(1):489-95
  • Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002;162(9):1028-32
  • Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med 2003;198(10):1563-72
  • Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 2008;59:343-59
  • Claudia zuany-Amorim JH. Christoph Walker. Toll-like receptors as potential therapeutic targets for multiple diseases. Nature Reviews/Drug discovery 2002;1:11
  • Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000;55(Suppl 1):S2-10
  • Cookson JB. Prevalence rates of asthma in developing countries and their comparison with those in Europe and North America. Chest 1987;91(6 Suppl):97S-103S
  • Skoogh BE. Parasympathetic ganglia in the airways. Bull Eur Physiopathol Respir 1986;22(Suppl 7):143-7
  • Myers AC, Undem BJ. Muscarinic receptor regulation of synaptic transmission in airway parasympathetic ganglia. Am J Physiol 1996;270(4 Pt 1):L630-6
  • Aaron SD. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. J Asthma 2001;38(7):521-30
  • Coulson FR, Fryer AD. Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther 2003;98(1):59-69
  • Gosens R, Zaagsma J, Grootte Bromhaar M, et al. Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur J Pharmacol 2004;500(1-3):193-201
  • Billington CK, Penn RB. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003;4:2
  • Hirshman CA, Lande B, Croxton TL. Role of M2 muscarinic receptors in airway smooth muscle contraction. Life Sci 1999;64(6-7):443-8
  • Thomas SS, Chhabra SK. A study on the serum levels of interleukin-1beta in bronchial asthma. J Indian Med Assoc 2003;101(5):282, 284, 286 passim
  • Sims JE, Nicklin MJ, Bazan JF, et al. A new nomenclature for IL-1-family genes. Trends Immunol 2001;22(10):536-7
  • Arsalane K, Gosset P, Vanhee D, et al. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1995;13(1):60-8
  • Jarjour N.N, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995 152(5 Pt 1):1474-7
  • Sousa AR, Lane SJ, Nakhosteen JA, et al. Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 1996;154(4 Pt 1):1061-6
  • Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87(6):2095-147
  • Okada S, Inoue H, Yamauchi K, et al. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin Immunol 1995;95(6):1236-45
  • Gasse P, Mary C, Guenon I, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007;117(12):3786-99
  • He R, Oyoshi MK, Jin H, Geha RS. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci USA 2007;104(40):15817-22
  • Whelan R, Kim C, Chen M, et al. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. Eur Respir J 2004;24(4):559-67
  • O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008;226:10-18
  • Basak C, Pathak SK, Bhattacharyya A, et al. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem 2005;280(6):4279-88
  • Krause K, Metz M, Makris M, et al. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 2012;12(5):477-84
  • Birrell MA, Eltom S. The role of the NLRP3 inflammasome in the pathogenesis of airway disease. Pharmacol Ther 2011;130(3):364-70
  • Paula FM, Barbosa HC, Carneiro EM, et al. Requirement of NF-kappaB signalling pathway for modulation of the cholinergic muscarinic M3 receptor expression by INGAP-PP in insulin-producing cells. Eur J Pharmacol 2010;642(1-3):37-46
  • Williams C, Crossland L, Finnerty J, et al. Case-control study of salmeterol and near-fatal attacks of asthma. Thorax 1998;53(1):7-13
  • Ahmad T, Barnes PJ, Adcock IM. Overcoming steroid insensitivity in smoking asthmatics. Curr Opin Investig Drugs 2008;9(5):470-7
  • Foster JM, Aucott L, van der Werf RH, et al. Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis. Respir Med 2006;100(8):1318-36
  • Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144(12):904-12
  • Ammit AJ, Burgess JK, Hirst SJ, et al. The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulm Pharmacol Ther 2009;22(5):446-54
  • van Noord JA, Bantje TA, Eland ME, et al. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax 2000;55(4):289-94
  • Desai D, Brightling C. Cytokines and cytokine-specific therapy in asthma. Adv Clin Chem 2012;57:57-97
  • Liu ZC, Wang YY, Zou MJ, et al. Effects of interleukin 1 receptor antagonist on allergy asthma in rat model and its mechanism. Zhonghua Yi Xue Za Zhi 2008;88(34):2432-6
  • Li T, Lu WL, Hong HY, et al. Pharmacokinetics and anti-asthmatic potential of non-parenterally administered recombinant human interleukin-1 receptor antagonist in animal models. J Pharmacol Sci 2006;102(3):321-30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.